Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOZAPINE for Parkinson's disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 214 adverse event reports in the FDA FAERS database where CLOZAPINE was used for Parkinson's disease.

Most Reported Side Effects for CLOZAPINE

Side Effect Reports % Deaths Hosp.
Neutropenia 18,981 19.9% 340 2,122
Hospitalisation 12,144 12.7% 227 12,132
Death 9,500 9.9% 9,498 877
Schizophrenia 3,991 4.2% 251 2,908
White blood cell count decreased 3,454 3.6% 203 1,578
Off label use 3,192 3.3% 403 1,674
Neutrophil count increased 3,125 3.3% 497 1,493
Drug ineffective 3,105 3.3% 98 1,561
Neutrophilia 3,105 3.3% 544 1,292
White blood cell count increased 2,988 3.1% 336 1,252
Neutrophil count decreased 2,523 2.6% 189 1,108
Treatment noncompliance 2,521 2.6% 63 2,026
Malaise 2,458 2.6% 247 1,777
Haemoglobin decreased 2,396 2.5% 159 920
Pneumonia 2,129 2.2% 647 1,565

Other Indications for CLOZAPINE

Product used for unknown indication (45,394) Schizophrenia (33,437) Schizoaffective disorder (2,553) Psychotic disorder (2,276) Bipolar disorder (797) Schizoaffective disorder bipolar type (452) Schizophrenia, paranoid type (432) Mental disorder (279) Hallucination (227) Borderline personality disorder (202)

Other Drugs Used for Parkinson's disease

CARBIDOPA\LEVODOPA (44,842) PIMAVANSERIN (20,674) LEVODOPA (5,425) APOMORPHINE (5,343) ISTRADEFYLLINE (4,479) ROTIGOTINE (3,895) DROXIDOPA (3,468) FOSCARBIDOPA\FOSLEVODOPA (2,446) RASAGILINE (1,910) PRAMIPEXOLE (1,799)

Related Pages

CLOZAPINE Full Profile All Parkinson's disease Drugs CLOZAPINE Demographics CLOZAPINE Timeline